Cancer BiologybioRxivPreprint
CCR2 is a potential biomarker and therapeutic target in Group 3 medulloblastoma
Carlos Custodia, Rita Cascão, Eunice Paisana…·Claudia C Faria
This study identifies CCR2 as a biomarker and therapeutic target in Group 3 medulloblastoma, showing its association with dissemination and poor survival, and demonstrating therapeutic efficacy through Cenicriviroc.
DOI 10.64898/2026.10.11.757412